Therefore, the high level of LINC00263 is expected to be one of the indicators of tamoxifen resistance in breast cancer, and the relationship between estrogen and the NF-κB-signaling pathway is expected to become a breakthrough in sex-specific cancers. The gene discussed is NFKB1; the disease is breast carcinoma.